US Stock MarketDetailed Quotes

SAM Boston Beer

Watchlist
  • 299.230
  • -2.990-0.99%
Trading Dec 27 12:45 ET
3.44BMarket Cap43.94P/E (TTM)

Boston Beer Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 28, 2024
(Q2)Jun 29, 2024
(Q1)Mar 30, 2024
(FY)Dec 30, 2023
(Q4)Dec 30, 2023
(Q3)Sep 30, 2023
(Q2)Jul 1, 2023
(Q1)Apr 1, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-11.72%115.87M
-19.30%96M
72.60%-4.88M
32.61%265.15M
230.96%32.75M
26.89%131.26M
-26.80%118.96M
56.54%-17.82M
255.16%199.95M
-569.02%-25.01M
Net income from continuing operations
-26.01%33.51M
-9.81%52.34M
240.65%12.6M
13.36%76.25M
-58.75%-18.12M
66.00%45.3M
8.78%58.04M
-358.11%-8.96M
362.19%67.26M
77.95%-11.42M
Operating gains losses
---241K
--1K
88.21%-23K
----
----
----
--0
-1,028.57%-195K
----
----
Depreciation and amortization
4.00%23.92M
8.72%23.58M
6.79%23.4M
8.34%88.14M
4.60%21.54M
10.28%23M
6.96%21.69M
11.62%21.92M
12.84%81.36M
7.56%20.59M
Deferred tax
-112.20%-19.46M
126.51%198K
97.44%-11K
-219.50%-10.87M
-107.57%-522K
-2,462.01%-9.17M
-129.46%-747K
-2,147.62%-430K
274.11%9.1M
66.42%6.9M
Other non cash items
2.13%2.11M
0.00%1.89M
7.93%2.01M
-1.97%7.9M
18.04%2.08M
-8.39%2.07M
-5.74%1.89M
-8.48%1.87M
5.80%8.06M
-9.77%1.76M
Change In working capital
-37.37%29.75M
-66.89%10.72M
-37.58%-50.33M
769.31%64.94M
145.10%21.64M
111.23%47.51M
-59.29%32.37M
42.60%-36.58M
86.11%-9.7M
-298.67%-47.98M
-Change in receivables
8.17%31.43M
-42.00%-52.45M
73.03%-6.3M
-406.37%-10.34M
-41.43%20.91M
8.72%29.05M
-111.11%-36.94M
50.24%-23.37M
-108.85%-2.04M
26.36%35.7M
-Change in inventory
-165.20%-8.58M
65.11%-2.22M
-877.42%-29.34M
23,945.80%31.5M
-38.84%27.71M
140.91%13.16M
-252.35%-6.37M
73.21%-3M
100.62%131K
-9.15%45.32M
-Change in prepaid assets
-7.12%9.81M
-86.06%3.65M
87.54%-1.32M
-36.38%41.74M
297.28%15.62M
-17.11%10.56M
-51.54%26.16M
-256.24%-10.61M
199.85%65.61M
66.64%-7.92M
-Change in payables and accrued expense
-773.19%-2.24M
4.87%60.54M
-540.16%-11M
131.50%16.65M
61.01%-43.91M
-98.66%332K
25.58%57.73M
122.92%2.5M
-766.55%-52.85M
-300.70%-112.61M
-Change in other current assets
147.35%1.6M
----
----
58.31%-5.85M
155.24%3.52M
57.60%-3.37M
----
----
-146.20%-14.03M
-37,370.59%-6.37M
-Change in other current liabilities
-1.57%-2.27M
1.31%-2.19M
-12.41%-2.36M
-34.42%-8.76M
-5.37%-2.22M
-44.31%-2.23M
-54.10%-2.22M
-46.71%-2.1M
20.82%-6.52M
1.08%-2.1M
Cash from discontinued investing activities
Operating cash flow
-11.72%115.87M
-19.30%96M
72.60%-4.88M
32.61%265.15M
230.96%32.75M
26.89%131.26M
-26.80%118.96M
56.54%-17.82M
255.16%199.95M
-569.02%-25.01M
Investing cash flow
Cash flow from continuing investing activities
-33.92%-16.68M
-16.32%-20.35M
-108.65%-35.71M
29.52%-62.38M
18.13%-15.31M
36.16%-12.46M
34.21%-17.5M
27.78%-17.12M
39.63%-88.51M
30.79%-18.7M
Net PPE purchase and sale
-33.92%-16.68M
-16.32%-20.35M
8.20%-15.71M
29.52%-62.38M
18.13%-15.31M
36.16%-12.46M
34.21%-17.5M
27.78%-17.12M
39.69%-88.51M
30.79%-18.7M
Net other investing changes
--0
--0
---20M
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
-33.92%-16.68M
-16.32%-20.35M
-108.65%-35.71M
29.52%-62.38M
18.13%-15.31M
36.16%-12.46M
34.21%-17.5M
27.78%-17.12M
39.63%-88.51M
30.79%-18.7M
Financing cash flow
Cash flow from continuing financing activities
-298.38%-62.89M
-279.89%-61.8M
-127.44%-52.45M
-3,130.07%-84.84M
-1,440.91%-29.73M
-5,175.88%-15.79M
-17.17%-16.27M
-262.92%-23.06M
142.16%2.8M
47.60%2.22M
Net issuance payments of debt
-6.20%-411K
-31.85%-505K
-34.54%-557K
5.80%-1.58M
2.74%-391K
3.25%-387K
97.51%-383K
-102.85%-414K
-6.50%-1.67M
-3.34%-402K
Net common stock issuance
-279.72%-63M
-154.09%-62.99M
-136.86%-49.97M
---92.88M
---30.4M
---16.59M
---24.79M
---21.1M
--0
--0
Proceeds from stock option exercised by employees
-56.45%520K
-81.16%1.7M
8.37%479K
47.53%11.72M
-59.41%1.06M
66.53%1.19M
247.08%9.02M
-78.01%442K
-24.07%7.95M
38.28%2.62M
Net other financing activities
33.33%-2K
--0
-20.62%-2.4M
39.18%-2.11M
--0
50.00%-3K
89.25%-117K
16.26%-1.99M
77.64%-3.47M
--0
Cash from discontinued financing activities
Financing cash flow
-298.38%-62.89M
-279.89%-61.8M
-127.44%-52.45M
-3,130.07%-84.84M
-1,440.91%-29.73M
-5,175.88%-15.79M
-17.17%-16.27M
-262.92%-23.06M
142.16%2.8M
47.60%2.22M
Net cash flow
Beginning cash position
5.55%219.3M
67.63%205.44M
65.31%298.49M
172.25%180.56M
39.96%310.78M
50.76%207.76M
677.22%122.56M
172.25%180.56M
-59.38%66.32M
156.69%222.05M
Current changes in cash
-64.76%36.31M
-83.74%13.85M
-60.43%-93.05M
3.23%117.93M
70.39%-12.29M
22.28%103.02M
-30.19%85.2M
-14.73%-58M
217.82%114.24M
-105.57%-41.49M
End cash Position
-17.75%255.6M
5.55%219.3M
67.63%205.44M
65.31%298.49M
65.31%298.49M
39.96%310.78M
50.76%207.76M
677.22%122.56M
172.25%180.56M
172.25%180.56M
Free cash flow
-15.43%99.19M
-25.44%75.65M
41.31%-20.62M
83.85%201.06M
138.52%17.44M
39.74%117.3M
-25.11%101.46M
45.76%-35.13M
219.36%109.36M
-108.65%-45.28M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 28, 2024(Q2)Jun 29, 2024(Q1)Mar 30, 2024(FY)Dec 30, 2023(Q4)Dec 30, 2023(Q3)Sep 30, 2023(Q2)Jul 1, 2023(Q1)Apr 1, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -11.72%115.87M-19.30%96M72.60%-4.88M32.61%265.15M230.96%32.75M26.89%131.26M-26.80%118.96M56.54%-17.82M255.16%199.95M-569.02%-25.01M
Net income from continuing operations -26.01%33.51M-9.81%52.34M240.65%12.6M13.36%76.25M-58.75%-18.12M66.00%45.3M8.78%58.04M-358.11%-8.96M362.19%67.26M77.95%-11.42M
Operating gains losses ---241K--1K88.21%-23K--------------0-1,028.57%-195K--------
Depreciation and amortization 4.00%23.92M8.72%23.58M6.79%23.4M8.34%88.14M4.60%21.54M10.28%23M6.96%21.69M11.62%21.92M12.84%81.36M7.56%20.59M
Deferred tax -112.20%-19.46M126.51%198K97.44%-11K-219.50%-10.87M-107.57%-522K-2,462.01%-9.17M-129.46%-747K-2,147.62%-430K274.11%9.1M66.42%6.9M
Other non cash items 2.13%2.11M0.00%1.89M7.93%2.01M-1.97%7.9M18.04%2.08M-8.39%2.07M-5.74%1.89M-8.48%1.87M5.80%8.06M-9.77%1.76M
Change In working capital -37.37%29.75M-66.89%10.72M-37.58%-50.33M769.31%64.94M145.10%21.64M111.23%47.51M-59.29%32.37M42.60%-36.58M86.11%-9.7M-298.67%-47.98M
-Change in receivables 8.17%31.43M-42.00%-52.45M73.03%-6.3M-406.37%-10.34M-41.43%20.91M8.72%29.05M-111.11%-36.94M50.24%-23.37M-108.85%-2.04M26.36%35.7M
-Change in inventory -165.20%-8.58M65.11%-2.22M-877.42%-29.34M23,945.80%31.5M-38.84%27.71M140.91%13.16M-252.35%-6.37M73.21%-3M100.62%131K-9.15%45.32M
-Change in prepaid assets -7.12%9.81M-86.06%3.65M87.54%-1.32M-36.38%41.74M297.28%15.62M-17.11%10.56M-51.54%26.16M-256.24%-10.61M199.85%65.61M66.64%-7.92M
-Change in payables and accrued expense -773.19%-2.24M4.87%60.54M-540.16%-11M131.50%16.65M61.01%-43.91M-98.66%332K25.58%57.73M122.92%2.5M-766.55%-52.85M-300.70%-112.61M
-Change in other current assets 147.35%1.6M--------58.31%-5.85M155.24%3.52M57.60%-3.37M---------146.20%-14.03M-37,370.59%-6.37M
-Change in other current liabilities -1.57%-2.27M1.31%-2.19M-12.41%-2.36M-34.42%-8.76M-5.37%-2.22M-44.31%-2.23M-54.10%-2.22M-46.71%-2.1M20.82%-6.52M1.08%-2.1M
Cash from discontinued investing activities
Operating cash flow -11.72%115.87M-19.30%96M72.60%-4.88M32.61%265.15M230.96%32.75M26.89%131.26M-26.80%118.96M56.54%-17.82M255.16%199.95M-569.02%-25.01M
Investing cash flow
Cash flow from continuing investing activities -33.92%-16.68M-16.32%-20.35M-108.65%-35.71M29.52%-62.38M18.13%-15.31M36.16%-12.46M34.21%-17.5M27.78%-17.12M39.63%-88.51M30.79%-18.7M
Net PPE purchase and sale -33.92%-16.68M-16.32%-20.35M8.20%-15.71M29.52%-62.38M18.13%-15.31M36.16%-12.46M34.21%-17.5M27.78%-17.12M39.69%-88.51M30.79%-18.7M
Net other investing changes --0--0---20M----------------------------
Cash from discontinued investing activities
Investing cash flow -33.92%-16.68M-16.32%-20.35M-108.65%-35.71M29.52%-62.38M18.13%-15.31M36.16%-12.46M34.21%-17.5M27.78%-17.12M39.63%-88.51M30.79%-18.7M
Financing cash flow
Cash flow from continuing financing activities -298.38%-62.89M-279.89%-61.8M-127.44%-52.45M-3,130.07%-84.84M-1,440.91%-29.73M-5,175.88%-15.79M-17.17%-16.27M-262.92%-23.06M142.16%2.8M47.60%2.22M
Net issuance payments of debt -6.20%-411K-31.85%-505K-34.54%-557K5.80%-1.58M2.74%-391K3.25%-387K97.51%-383K-102.85%-414K-6.50%-1.67M-3.34%-402K
Net common stock issuance -279.72%-63M-154.09%-62.99M-136.86%-49.97M---92.88M---30.4M---16.59M---24.79M---21.1M--0--0
Proceeds from stock option exercised by employees -56.45%520K-81.16%1.7M8.37%479K47.53%11.72M-59.41%1.06M66.53%1.19M247.08%9.02M-78.01%442K-24.07%7.95M38.28%2.62M
Net other financing activities 33.33%-2K--0-20.62%-2.4M39.18%-2.11M--050.00%-3K89.25%-117K16.26%-1.99M77.64%-3.47M--0
Cash from discontinued financing activities
Financing cash flow -298.38%-62.89M-279.89%-61.8M-127.44%-52.45M-3,130.07%-84.84M-1,440.91%-29.73M-5,175.88%-15.79M-17.17%-16.27M-262.92%-23.06M142.16%2.8M47.60%2.22M
Net cash flow
Beginning cash position 5.55%219.3M67.63%205.44M65.31%298.49M172.25%180.56M39.96%310.78M50.76%207.76M677.22%122.56M172.25%180.56M-59.38%66.32M156.69%222.05M
Current changes in cash -64.76%36.31M-83.74%13.85M-60.43%-93.05M3.23%117.93M70.39%-12.29M22.28%103.02M-30.19%85.2M-14.73%-58M217.82%114.24M-105.57%-41.49M
End cash Position -17.75%255.6M5.55%219.3M67.63%205.44M65.31%298.49M65.31%298.49M39.96%310.78M50.76%207.76M677.22%122.56M172.25%180.56M172.25%180.56M
Free cash flow -15.43%99.19M-25.44%75.65M41.31%-20.62M83.85%201.06M138.52%17.44M39.74%117.3M-25.11%101.46M45.76%-35.13M219.36%109.36M-108.65%-45.28M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
+0.58%
Halozyme Therapeutics
HALO
+0.02%
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
0.00%
YETI Holdings
YETI
-0.81%
Precision Drilling
PDS
-0.87%

Unlock the Full List